| Literature DB >> 27640188 |
Wolf Siepen1, Lukas Zwicky2, Karl Kilian Stoffel2, Thomas Ilchmann3, Martin Clauss2.
Abstract
BACKGROUND: Cemented stems show good long-term results and the survival of new implants can be predicted by their early subsidence. With EBRA-FCA (Femoral Component Analysis using Einzel-Bild-Röntgen-Analyse) early subsidence as an early indicator for later aseptic loosening can be analysed. For the cemented TwinSys stem mid- and long-term data is only avalible from the New Zeeland Arthroplasty register, thus close monitoring of this implant system is still mandatory.Entities:
Keywords: Cemented; EBRA-FCA; RM pressfit; Straight stem; Subsidence; twinSys
Mesh:
Substances:
Year: 2016 PMID: 27640188 PMCID: PMC5027091 DOI: 10.1186/s12891-016-1247-9
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Distribution of the measuring points used to measure and calculate the subsidence in the EBRA-FCA software
Fig. 2CONSORT flow chart of the included patients and the follow-ups
Harris Hip Score during the time line, differentiation between transglutral an anterior (MIS) approach
| Time point | HHS all | Transgluteal | MIS |
|
|---|---|---|---|---|
| preOP | 56 (14–86) | 57 (20–86) | 56 (14–85) | 0.64 |
| 6 weeks | 82 (49–100) | 75.5 (49–94) | 84 (51–100) | 0.06 |
| 12 weeks | 93 (66–100) | 87.5 (70–100) | 94 (66–100) | 0.8 |
| 1 year | 99 (25–100) | 99 (75–100) | 99 (25–100) | 0.59 |
| 2 year | 95 (60–100) | 95 (79–100) | 95 (60–100) | 0.91 |
Distribution of the subsidences measured by EBRA-FCA and the corresponding details about alignemnt, cementing quality and offset
| CRI | Patient | Subsidence EBRA-FCA (mm) | Alignement | Cementing Quality (Barrack) | Standard/Lateralised Offset |
|---|---|---|---|---|---|
| 195 | 1 | 1.01 | Valgus | A | Lateralised |
| 326 | 2 | 1.04 | Neutral | A | Lateralised |
| 182 | 3 | 1.23 | Neutral | C | Lateralised |
| 315 | 4 | 1.26 | Neutral | A | Lateralised |
| 347 | 5 | 1.31 | Neutral | B | Lateralised |
| 403 | 6 | 1.32 | Neutral | A | Standard |
| 338 | 7 | 1.35 | Valgus | A | Standard |
| 324 | 8 | 1.37 | Neutral | A | Lateralised |
| 345 | 9 | 1.44 | Neutral | A | Standard |
| 244 | 10 | 1.51 | Neutral | A | Standard |
| 288 | 11 | 3.08 | Neutral | B | Standard |
Overview of the different implants and their long-term survival for aseptic lossening
| Author | Year | Type | Implant | Fixation type | Survivalrate and time |
|---|---|---|---|---|---|
| Clauss M [ | 2009 | Follow-up | Müller straight stem | Shape-closed | 87 % survival 20 years for aseptic loosening |
| Espehaug B [ | 2009 | Register | Exeter | Force-closed | 90 % survival 20 years for aseptic loosening |
| Titan | Shape-closed | 93 % survival 19 years for aseptic loosening | |||
| Spectron | Shape-closed | 90 % survival 17 years for aseptic loosening | |||
| Ling RS [ | 2009 | Follow-up | Exeter | Force-closed | 93,5 % survival 33 years for aseptic loosening |
| Makela K [ | 2008 | Register | Exeter | Force-closed | >90 % survival 15 years for aseptic loosening |
| Müller straight stem | Shape-closed | >90 % survival 15 years for aseptic loosening | |||
| Ogino D [ | 2008 | Register | Lubinus | Shape-closed | 95,5 % survival 23 years for aseptic loosening |
| Exeter | Force-closed | 95 % survival 15 years for aseptic loosening |